Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer

被引：1

作者：

Genova, Carlo ^{[1
]}

Carrega, Paolo ^{[2
]}

Distefano, Roberta ^{[1
]}

Ottonello, Selene ^{[3
]}

Pietra, Gabriella ^{[3
]}

Cossu, Irene ^{[2
]}

Rijavec, Erika ^{[1
]}

Biello, Federica ^{[1
]}

Rossi, Giovanni ^{[1
]}

Barletta, Giulia ^{[1
]}

Dal Bello, Maria Giovanna ^{[1
]}

Alama, Angela ^{[1
]}

Coco, Simona ^{[1
]}

Vanni, Irene ^{[1
]}

Maggioni, Claudia ^{[1
]}

Merlo, Franco ^{[4
]}

Mingari, Maria Cristina ^{[3
]}

Grosse, Francesco ^{[1
]}

机构：

[1] San Martino Hosp, Natl Inst Canc Res, Lung Canc Unit, Genoa, Italy

[2] Giannina Gaslini Inst, Lab Clin & Expt Immunol, Genoa, Italy

[3] San Martino Hosp, Natl Inst Canc Res, Dept Expt Med, Genoa, Italy

[4] San Martino Hosp, Natl Inst Canc Res, Clin Trials Unit, Genoa, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

local cancerimmunotherapy; Lewis lung cancer; photoimmunotherapy; regulatory T cell;

D O I：

10.1016/j.jtho.2016.11.1867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02c-072

引用

页码：S1320 / S1321

页数：3

共 50 条

[31] TUMOR ENDOTHELIAL MARKERS (TEMS) AS PROGNOSTIC AND PREDICTIVE MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
Pircher, A.
Untergasser, G.
Heidegger, I. M.
Kern, J.
Gunsilius, E.
Fiegl, M.
Hilbe, W.
[J]. ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
[32] Durable complete response to nivolumab in a patient with HIV and metastatic non-small cell lung cancer
McCullar, Brennan
Alloway, Taylor
Martin, Michael
[J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (06) : E540 - E542
[33] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
Sabine Schmid
Stefan Diem
Qiyu Li
Mirjam Krapf
Lukas Flatz
Sebastian Leschka
Lotus Desbiolles
Dirk Klingbiel
Wolfram Jochum
Martin Früh
[J]. Cancer Immunology, Immunotherapy, 2018, 67 : 1825 - 1832
[34] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
Schmid, Sabine
Diem, Stefan
Li, Qiyu
Krapf, Mirjam
Flatz, Lukas
Leschka, Sebastian
Desbiolles, Lotus
Klingbiel, Dirk
Jochum, Wolfram
Fruh, Martin
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (12) : 1825 - 1832
[35] Nivolumab in non-small cell lung cancer: is there an upper age limit?
De Pietro, L.
Vitiello, F.
Gilli, M.
Letizia, A.
Tortoriello, A.
Hengeller, M.
Mazzarella, G.
Bianco, A.
Piantedosi, F.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[36] Nivolumab: A Review in Advanced Nonsquamous Non-Small Cell Lung Cancer
Keating, Gillian M.
[J]. DRUGS, 2016, 76 (09) : 969 - 978
[37] Nivolumab: A Review in Advanced Squamous Non-Small Cell Lung Cancer
Keating, Gillian M.
[J]. DRUGS, 2015, 75 (16) : 1925 - 1934
[38] Nivolumab: A Review in Advanced Nonsquamous Non-Small Cell Lung Cancer
Gillian M. Keating
[J]. Drugs, 2016, 76 : 969 - 978
[39] Nivolumab: A Review in Advanced Squamous Non-Small Cell Lung Cancer
Gillian M. Keating
[J]. Drugs, 2015, 75 : 1925 - 1934
[40] Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution
Salati, Massimiliano
Baldessari, Cinzia
Cerbelli, Bruna
Botticelli, Andrea
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S91 - S94

← 1 2 3 4 5 →